Navigation Links
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
Date:3/20/2008

NEW YORK, March 20 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

Autoimmune-Inflammation Index (HHA)

Drop

GW Pharmaceuticals, Inc (LSE: GWP.L)

Human Genome Sciences (Nasdaq: HGSI)

Ligand Pharmaceuticals, Inc. (Nasdaq: LGND)

Add

Fornix Biosciences N.V. (Amsterdam: FORBI.AS)

Meda AB (SHSE1: MEDA A)

Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Cancer Index (HHK)

Drop

Shire PLC (Nasdaq: SHPGY)

Add

Ark Therapeutics Group Plc (LSE: AKT.L)

Cardio Devices Index (HHE)

Drop

Biosphere Medical, Inc. (Nasdaq: BSMD)

Add

Zoll Medical Corp. (Nasdaq: Add

Dyanvax Technologies (Nasdaq: DVAX)

Synta Pharmaceuticals Corp. (Nasdaq: SNTA)

Enabling Technologies Index (HHV)

Drop

Hillenbrand Industries (NYSE: HB)

Add

Eurand N.V. (Nasdaq: EURX)

GI/Gender Index (HHU)

Drop

AEterna Zentaris (Nasdaq: AEZS)

King Pharmaceuticals (NYSE: KG)

Nastech Pharmaceutical (Nasdaq: NSTK)

Add

Columbia Laboratories Inc. (Nasdaq: CBRX)

Eisai Co. Ltd. (Tokyo Stock Exchange: 4523)

Mylan, Inc. (NYSE: MYL)

Metabolic-Endocrine Disorders Index (HHM)

Drop

Depomed Inc. (Nasdaq: DEPO)

Emisphere Technologies Inc. (Nasdaq: EMIS)

Flamel Technologies SA ADS (Nasdaq: FLML)

Hospira Inc. (NYSE: HSP)

Human Genome Sciences, Inc. (Nasdaq: HGSI)

Indevus Pharmaceuticals Inc. (Nasdaq: IDEV)

Ipsen Ltd. (Paris: IPN.PR)

Nektar Therapeutics (Nasdaq: NKTR)

NicOx S.A. (Paris: NCOX)

OSI Pharmaceuticals Inc. (Nasdaq: OSIP)

ProStrakan Group Plc (LSE: PSK.L)

Solvay S.A. (Brussels: SVYSY)

Add

Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

Amicus Therapeutics, Inc. (Nasdaq: FOLD)

Biodell Inc. (Nasdaq: BIOD)

CombinatoRx Inc. (Nasdaq: CRXX)

GW Pharmaceuticals Plc (LSE: GWP.L)

Incyte Corp. (Nasdaq: INCY)

Orexigen Therapeutics, Inc. (Nasdaq: OREX)

Repros Therapeutics Inc. (Nasdaq: RPRX)

Sirtris Pharmaceuticals, Inc. (Nasdaq: SIRT)

SuperGen Inc. (Nasdaq: SUPG)

Transition Therapeutics Inc. (Nasdaq: TTHI)

XOMA Ltd. (Nasdaq: XOMA)

Neuroscience Index (HHN)

Drop

Neurochem Inc. (Nasdaq: NRMX)

Add

Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Ophthalmology Index (HHZ)

Drop

Insite Vision Inc. (Amex: ISV)

Add

King Pharmaceuticals (NYSE: KG)

Patient Care Services Index (HHB)

Drop

Fresenius Medical Care (XETRA: FME.DE)

Add

Coventry Health Care Inc. (NYSE: CVH)

The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008.

In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at http://www.healthsharesinc.com/content/view/53/274/.

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at http://www.qedinternational.com

ick="var s=s_gi(s_account); var hd1 = document.getElementById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >ZOLL)

Cardiology Index (HRD)

Drop

Encysive Pharmaceuticals, Inc. (Nasdaq: ENCY)

Human Genome Sciences, Inc (Nasdaq: HGSI)

Vical, Inc. (Nasdaq: VICL)

Add

Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Sangamo BioSciences Inc. (Nasdaq: SGMO)

Sciele Pharma, Inc. (Nasdaq: SCRX)

Composite Index (HHQ)

Drop

Advanced Medical Optics, Inc. (NYSE: EYE)

Align Technology Inc. (Nasdaq: ALGN)

Array Biopharma Inc. (Nasdaq: ARRY)

ArthroCare Corp. (Nasdaq: ARTC)

Endo Pharmaceuticals Hldgs. (Nasdaq: ENDP)

Fresenius Medical Care AG (XETRA: FME.DE)

GEDEON RICHTER RT (XETRA: R1G1.DE)

GENMAB A/S (Copenhagen: GEN.CO)

H LUNDBECK A/S (Copenhagen: LUN.CO)

Human Genome Sciences (Nasdaq: HGSI)

Imclone Systems (Nasdaq: IMCL)

Inverness Medical Innovations (Amex: IMA)

Invitrogen Corp. (Nasdaq: IVGN)

Medarex Inc. (Nasdaq: MEDX)

Medicis Pharmaceutical (NYSE: MRX)

Mentor Corp. (NYSE: MNT)

ONYX Pharmaceuticals Inc. (Nasdaq: ONXX)

PDL BioPharma, Inc. (Nasdaq: PDLI)

Pharmion Corp. (Nasdaq: PHRM)

Progenics Pharmaceuticals Inc. (Nasdaq: PGNX)

Regeneron Pharmaceuticals (Nasdaq: REGN)

Respironics Inc. (Nasdaq: RESP)

Sepracor Inc. (Nasdaq: SEPR)

Theravance Inc. (Nasdaq: THRX)

United Therapeutics Corp. (Nasdaq: UTHR)

Valeant Pharmaceuticals Int'l (NYSE: VRX)

Vertex Pharmaceuticals (Nasdaq: VRTX)

Add

Adolor Corp. (Nasdaq: ADLR)

ALLOS THERAPEUTICS INC. (Nasdaq: ALTH)

Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY)

Alpharma Inc. (NYSE: ALO)

Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

AMAG Pharmaceuticals Inc. (Nasdaq: AMAG)

ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI)

Ark Therapeutics (LSE: AKT.L)

Bavarian Nordic A/S (Copenhagen: BAVA.CO)

Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Cardiome Pharma Corp. (Nasdaq: CRME)

Coventry Health Care Inc. (NYSE: CVH)

CRUCELL-ADR (Nasdaq: CRXL)

CUBIST PHARMACEUTICALS INC. (Nasdaq: CBST)

Discovery Laboratories Inc. (Nasdaq: DSCO)

Eisai Co. Ltd. (TSE: 4523.T)

Encysive Pharmaceuticals Inc. (Nasdaq: ENCY)

Enzo Biochem Inc. (NYSE: ENZ)

ENZON PHARMACEUTICALS INC. (Nasdaq: ENZN)

Exelixis Inc. (Nasdaq: EXEL)

Flamel Technologies (Nasdaq: FLML)

Illumina Inc. (Nasdaq: ILMN)

Incyte Corporation (Nasdaq: INCY)

Integra LifeSciences Holdings (Nasdaq: IART)

Meda AB (Stockholm: MEDAA.ST)

Mitsubishi Tanabe Pharma (TSE: 4508.T)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535.T)

Dermatology and Wound Index (HRW)

Drop

Shire PLC (ADR) (Nasdaq: SHPGY)

SkyePharma Plc (LSE: SKP.LN)

Add

Standard Chemical & Pharm. Co., Ltd. (TSE: 1720)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535)

Diagnostics Index (HHD)

Drop

CR Bard, Inc. (NYSE: BCR)

IDEXX Laboratories (Nasdaq: IDXX)

Add

Bruker Corporation (Nasdaq: BRKR)

Halozyme Therapeutic (Nasdaq: HALO)

Emerging Cancer Index (HHJ)

Drop

Adventrx Pharmaceuticals, Inc. (Amex: ANX)

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX)

'/>"/>
SOURCE QED International Associates Inc.,
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
2. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
3. China Yingxia International Announces Q4 and FY 2007 Estimates
4. CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement
5. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
6. International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy
7. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
8. QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
9. IBF Conferences Inc., (International Business Forum) and BioEnterprise Present the 2nd Annual Global Healthcare Investing Conference
10. PAREXEL International Announces 2-For-1 Stock Split
11. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... ... dedicated to delivering cutting-edge information focused on the development and manufacture of ... become a premier sponsor of the 2016 BioProcess International Awards – Recognizing ...
(Date:2/11/2016)... Florida , February 11, 2016 ... PositiveID Corporation ("PositiveID" or "Company") (OTCQB: PSID), a ... announced today that its Thermomedics subsidiary, which markets ... on its growth plan in January 2016, including ... distributors, increasing sequential monthly sales growth, and establishing ...
(Date:2/11/2016)... ... February 11, 2016 , ... Reichert Technologies, ... continues today to pursue the highest level of accuracy and quality with the ... Refractometer and the AR5 Refractometer. Accurate, reliable and tough enough for the ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global Stem Cells ... in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques ... the world. , The new GSCG clinic is headed by four prominent ...
Breaking Biology Technology:
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
(Date:1/20/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce the attainment of record-setting corporate ... of the company,s laser focus on (and growing international ... comprehensive, easy-to-use and highly affordable cloud-based technology platform. ... growth achievements in 2015 include: , Record ...
(Date:1/18/2016)... Calif. , Jan. 18, 2016  Extenua ... software that simplifies the use and access of ... and go-to-market partnership with American Cyber.  ... brings extensive experience leading transformational C4ISR and Cyber ... and integrating the latest proven technology solutions," said ...
Breaking Biology News(10 mins):